Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation.

Silymarin, a plant flavonoid, has been shown to inhibit skin carcinogenesis in mice. However, the mechanism responsible for the anti-skin carcinogenic effects of silymarin is not clearly understood. Here, we report that treatment of JB6 C141 cells (preneoplastic epidermal keratinocytes) and p53+/+ fibroblasts with silymarin and silibinin (a major constituent of silymarin) resulted in a dose-dependent inhibition of cell viability and induction of apoptosis in an identical manner. Silymarin-induced apoptosis was determined by fluorescence staining (8-64% apoptosis) and flow cytometry (12-76% apoptosis). The silymarin-induced apoptosis was primarily p53 dependent because apoptosis occurred to a much greater extent in the cells expressing wild-type p53 (p53+/+, 9-61%) than in p53-deficient cells (p53-/-, 6-20%). The induction of apoptosis in JB6 C141 cells was associated with increased expression of the tumor suppressor protein, p53, and its phosphorylation at Ser15. The constitutive expression of antiapoptotic proteins Bcl-2 and Bcl-xl were decreased after silymarin treatment, whereas the expression of the proapoptotic protein Bax was increased. There was a shift in Bax/Bcl-2 ratio in favor of apoptotic signal in silymarin-treated cells, which resulted in increased levels of cytochrome c release, apoptotic protease-activating factor-1, and cleaved caspase-3 and poly(ADP-ribose) polymerase in JB6 C141 cells. The shift in Bax/Bcl-2 ratio was more prominent in p53+/+ fibroblasts than in p53-/- cells. Silymarin-induced apoptosis was blocked by the caspase inhibitor (Z-VAD-FMK) in JB6 C141 cells which suggested the role of caspase activation in the induction of apoptosis. These observations show that silymarin-induced apoptosis is primarily p53 dependent and mediated through the activation of caspase-3.

[1]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[2]  H. Mukhtar,et al.  Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappaB and induction of apoptosis , 2004, Oncogene.

[3]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[4]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[5]  S. Lowe,et al.  p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.

[6]  H. Wagner,et al.  [On the chemistry of silymarin (silybin), the active principle of the fruits from Silybum marianum (L.) Gaertn. (Carduus marianus L.)]. , 1968, Arzneimittel-Forschung.

[7]  S. Korsmeyer,et al.  bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Fisher.  Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[9]  R. Mohan,et al.  A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. , 1999, Cancer research.

[10]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[11]  J. Larrick,et al.  Inhibition of apoptosis as a mechanism of tumor promotion , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  B. Kaina.  DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. , 2003, Biochemical pharmacology.

[13]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[14]  H. Mannherz,et al.  Premature keratinocyte death and expression of marker proteins of apoptosis in human skin after UVB exposure , 2003, Archives of Dermatological Research.

[15]  S. Katiyar.  Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (Review). , 2005, International journal of oncology.

[16]  R. Agarwal,et al.  Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. , 1999, Cancer letters.

[17]  R Montesano,et al.  Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.

[18]  C. Elmets,et al.  Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. , 2003, Carcinogenesis.

[19]  K. Vousden,et al.  Regulation and function of the p53 tumor suppressor protein. , 2001, Current opinion in cell biology.

[20]  T. Cotter,et al.  Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. , 2004, Biochimica et biophysica acta.

[21]  A. Eastman,et al.  Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. , 1990, Biochemical pharmacology.

[22]  H. Horvitz,et al.  Mechanisms and functions of cell death. , 1991, Annual review of cell biology.

[23]  R. Agarwal,et al.  Protective effects of silymarin against photocarcinogenesis in a mouse skin model. , 1997, Journal of the National Cancer Institute.

[24]  Weiya Ma,et al.  Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. , 2003, Cancer research.

[25]  John Calvin Reed.  Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. , 1995, Current opinion in oncology.

[26]  Weiya Ma,et al.  Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. , 1999, Carcinogenesis.

[27]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[28]  D. Meek,et al.  Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 , 1999, The EMBO journal.

[29]  S. Katiyar,et al.  EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. , 2004, International journal of oncology.

[30]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[31]  N. Colburn,et al.  Tumour promoter induces anchorage independence irreversibly , 1979, Nature.

[32]  A. Levine,et al.  The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.

[33]  J. Hickman,et al.  Apoptosis induced by anticancer drugs , 1992, Cancer and Metastasis Reviews.

[34]  C. Larsen.  [The BCL2 gene, prototype of a gene family that controls programmed cell death (apoptosis)]. , 1994, Annales de genetique.

[35]  D. Pinkel,et al.  Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation , 1998, The EMBO journal.

[36]  Sung-ju Ahn,et al.  Involvement of NF-κB and caspases in silibinin-induced apoptosis of endothelial cells , 2004 .

[37]  P. O'Connor,et al.  Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. , 1994, Oncogene.

[38]  D. Housman,et al.  Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Korsmeyer,et al.  Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.

[40]  N. Colburn,et al.  Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells. , 1988, Cancer research.

[41]  Larsen Cj.  [The BCL2 gene, prototype of a gene family that controls programmed cell death (apoptosis)]. , 1994 .

[42]  B. Barres,et al.  Programmed cell death and the control of cell survival: lessons from the nervous system. , 1993, Science.

[43]  R. Agarwal,et al.  Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. , 2004, Carcinogenesis.

[44]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[45]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[46]  B. Hoffman,et al.  Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. , 1995, Oncogene.

[47]  G. Stark,et al.  Transgenic mice with p53‐responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo , 1997, The EMBO journal.

[48]  S. Katiyar.  Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin. , 2002, International journal of oncology.